Breast Cancer Survivor's Foundation to Hold 1st Run/Walk Event; Proceeds to Boost Cleveland Clinic Researcher's Work
The Plain Dealer - Sept 30, 2013
Still, Turchi, of Aurora, was captivated by the details surrounding the research that Dr. Vincent Tuohy, an immunologist with the Cleveland Clinic Lerner Research Institute and Case Comprehensive Cancer Center, had been conducting: a vaccine to prevent breast cancer and to keep it from coming back in women who had been treated for the disease.
Antidepressant May Treat Deadly Form of Lung Cancer, Study Finds
Everyday Health - Sept 27, 2013
A little-used class of antidepressants may be the newest weapon against a particular type of lung cancer, according to a new study published in the journal Cancer Discovery. Researchers from the Lucile Packard Children's Hospital at Stanford University found that the antidepressant imipramine was effective at treating small-cell lung cancer — a rare and difficult to beat form of lung cancer...Nathan Pennell, MD, PhD, an oncologist with the Cleveland Clinic and Case Comprehensive Cancer Center, said the findings are exciting, even with the small number of people affected by the disease...
Genetic Mutation Identified in Castration-resistant Prostate Cancer
Helio/HemOnc Today - Sept 26, 2013
"For patients with advanced prostate cancer, treatment can include testosterone deprivation therapy, which works most of the time, but then the tumors invariably become resistant," Case Comprehensive Cancer Center member, Nima Sharifi, MD, Kendrick family chair for prostate cancer research at Cleveland Clinic, told HemOnc Today.
Hyundai Hope on Wheels Donates $500,000 to Clinic and UH Children's Cancer Research
The Plain Dealer - Sept 24, 2013
Hyundai Hope on Wheels, a national effort by Hyundai Motors America to raise money for childhood cancer research, is donating a total of $500,000 to Cleveland children's hospitals this year. The Cleveland Clinic's Children's Hospital and University Hospitals Rainbow Babies & Children's Hospital are two of 41 grant recipients nationwide receiving a total of $10.25 million in funding...The grant to UH Rainbow will fund the work of Dr. Alex Huang, program director of pediatric hematology and oncology, whose research focuses on finding new treatments and therapies for T-cell leukemia. Since 2002, the hospital has received more than $1 million in funding from Hope on Wheels.
The Clinic Children's Hospital grant will fund the research ofDr. Gregory Plautz, department chair of pediatric hematology and oncology, who is working on ways to help the body's own immune system fight cancer. This is the Clinic's second award from Hope On Wheels. Plautz received a $100,000 grant from the program in 2010. Both Plautz and Huang are members of the Case Comprehensive Cancer Center in Cleveland.
Department Interview with Dr. Mukesh Jain
Department of Medicine eNewsletter - Sept 2013
Mukesh Jain, MD, Scientific Director of Harrington Discovery Institute at University Hospitals Case Medical Center, Chief Research Officer of University Hospitals Harrington Heart & Vascular Institute, Director of Case Cardiovascular Research Institute, and member of the Case Comprehensive Cancer Center at Case Western Reserve University, shares his insight on generating quality ideas that lead to NIH funding, offers perspective on effectively mentoring young investigators and discusses the future goals of the Harrington Discovery Institute.
Database of Potential Student Lab Assistants
The Cancer Center has a database of undergraduate and graduate students who are interested in working in cancer research labs or are doing rotations for the Biomedical Sciences Training Program. If you are interested in hosting a student volunteer, employee, or rotation, please contact Lyn Haselton at email@example.com. We appreciate your support and interest in training the next generation of cancer researchers.
Publication Support Acknowledgement
Please remember to acknowledge the valuable support provided by the Cancer Center and its core facilities in your research papers and publications:
"This research was supported by the Case Comprehensive Cancer Center (P30CA043703)." OR
"This research was supported by the [insert facility name] Core Facility of the Case Comprehensive Cancer Center (P30CA043703)."
New Treatment Paradigms for Melanoma: A Case-based Discussion
Registration is open for New Treatment Paradigms for Melanoma: A Case-based Discussion, presented by the Case Comprehensive Cancer Center on Friday, October 18 at the Holiday Inn-Cleveland South. This conference is intended to provide melanoma caregivers a case-driven overview of current melanoma treatment paradigms. Case CCC faculty will discuss multidisciplinary approaches to the management of early and late stage melanoma.
The conference will cover the integration of new diagnostic and treatment technologies in care of the melanoma patient. In addition, the role of new targeted and immune therapies in the melanoma treatment as well as management of associated novel toxicities will be reviewed. A case-based discussion format will provide the opportunity audience interaction with the course faculty. CME credit is available.
Graft-versus-Host Disease (GvHD) National Symposium
Registration today the Graft-versus-Host Disease (GvHD) National Symposium, Friday, November 1 at the Embassy Suites Cleveland. This conference is intended to raise awareness about the signs and symptoms of GvHD, review cutting edge approaches to prevention and treatment, and highlight and promote research to further our understanding of its cause. The symposium will have two tracks: a scientifically rigorous one for physicians and practitioners, and a survivor track that will focus on challenges faced by BMT recipients and their families. CME credit is available.
Conquer Cancer Foundation Advanced Clinical Research Award in Breast Cancer
The Conquer Cancer Foundation is accepting Letters of Intent for the 2014 Advanced Clinical Research Award in Breast Cancer. This award is designed to fund mid-career investigators who are committed to clinical cancer research and who wish to conduct original breast cancer research not currently funded.
LOI Deadline: October 21
Application Deadline: December 2
SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant
The American Association for Cancer Research is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant. The grant provides three years of funding for research projects that must include therapeutic interventions for pancreatic cancer and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional convergence Dream Team of experts. The project must bring together biology (e.g. genomics, epigenetics, proteomics, and/or other biological fields) and at least one additional field of research such as physics, engineering, or immunology.
Deadline: November 7
SU2C-Farrah Fawcett Foundation Human Papillomavirus (HPV) Translational Research Team Grant
The American Association for Cancer Research, on behalf of Stand Up To Cancer (SU2C) and The Farrah Fawcett Foundation, calls upon members of the cancer community to contribute their ideas to the groundbreaking Stand Up To Cancer (SU2C)-Farrah Fawcett Foundation Human Papillomavirus (HPV) Translational Research Team Grant. Ideas are invited for a multidisciplinary translational cancer research project that addresses critical problems in HPV-related cancers and that can deliver near-term patient benefit through investigation by a Team of two expert investigators. The selected grant will include a translational component, and have the potential for a significant impact for patients with HPV-related cancers.
Deadline: November 6
Alex's Lemonade Stand Foundation Innovation Awards
Alex's Lemonade Stand Foundation is accepting Letters of Intent for Innovation Awards. These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers.
LOI Deadline: November 11
Application Deadline: March 3, 2014
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Szent-Györgyi Prize for Progress in Cancer Research
AACR G.H.A. Clowes Memorial Award
Case CCC Protocol Specific Research Support (PSRS)
International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.
David Satcher Lecture Series
Jackson T. Wright, Jr, MD, PhD
Director, Clinical Hypertension Program and William T. Dahms MD Clinical Research Unit
Topic: Desperate Need for Minority Investigators in Academic Medicine: One Approach
11:45 am RBC Amphitheater
Pathology Pathology Research Seminar Series
Yiping W. Han, PhD
Topic: Fusobacterium Nucleatum: An Oral Commensalturned Causative Agent of Colorectal Cancer
12 pm WRB 1-413
Physiology and Biophysics Seminar
Jenny E. Hinshaw, PhD
Senior Investigator, Laboratory of Cell and Molecular Biology
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Topic: A Dynamin Mutant Defines a Super-constricted Pre-fission Step
4 pm SOM E-501
Skeletal Research Center
Rodrigo Somoza, PhD
Research Associate, Skeletal Research Center, Biology
Topic: TGF-β3 Secretion by Human Dental Apical Papilla Mesenchymal Stem Cells (hDAP-MSC) Encapsulated in Alginate and Fibrin Scaffolds
4 pm Millis 123
Immunology Seminar Series
Frederick W. Alt, PhD
Charles A. Janeway Professor of Pediatrics
Senior Investigator, Program in Cellular and Molecular Medicine
Harvard University/Boston Children's Hospital
Investigator, Howard Hughes Medical Institute Topic: Antibody Diversity, Genome Stability and Cancer
12 pm WRB 1-413
DNA Damage/Repair Focus Group Meeting
G. Valentin Börner, PhD
Associate Professor, Biology
Cleveland State University
Topic: Roles of the ATM/ATR Checkpoint in Meiotic DSB Repair
4 pm WRB 3-136
Jeremy Rich, MD
Professor and Chair, Stem Cell Biology and Regenerative Medicine
CWRU/Cleveland Clinic Topic: Partners in Crime: Cancer Stem Cells and the Microenvironment
4 pm NA5-03 Cleveland Clinic
Hematology and Oncology Research Conference
Deepjot Singh, MD
Assistant Professor, Div. of Hem/Onc
Topic: Managing Advanced Gastric Cancer in the Era of Personalized Medicine
8 am Lerner B-151
Metabolic Sciences Advisory Group
Chris Newgard, PhD
Director, Sarah W. Stedman Nutrition and Metabolism Center
Professor, Pharmacology and Cancer Biology
Topic: Diabetes Re-Examined: Role of Metabolic Fuel Selection
1 pm Wood 203
Pathology Thesis Defense
PhD Candidate, Schmaier Lab, Pathology
Topic: Angiotensin–(1–7)/Mas Axis Compensates Absent Bradykinin/B2R to Regulate Thrombosis Risk—A Tale of Two Mice
1 pm WRB 6-136
Prostate Cancer Working Group Seminar Series and Journal Club
Nicholas Mitsiades, MD, PhD
Assistant Professor, Medicine and Molecular & Cellular Biology
Topic: Steroid Receptor Coactivators: Master Transcriptional Regulators in Prostate Cancer
4 pm NE1-205 Cleveland Clinic
Immunology Journal Club
Graduate Student, Li Lab, Immunology
Topic: B Lymphocytes Trigger Monocyte Mobilization and Impair Heart Function After Acute Myocardial Infarction
12 pm WRB 5-136
Hematology/Oncology Fellows Conference/Curriculum Series
Alvin Schmaier, MD
Professor, Div. of Hem/Onc
Topic: Thrombotic Disorders and Anticoagulants
8 am Wearn 137/Breen Conference Rm
Taussig Cancer Institute Grand Rounds
Kriti Mittal, MD, MS
Hematologic Oncology and Blood Disorders
8 am R3/002-003 Cleveland Clinic
Cancer Center Seminar Series
12 pm BRB 105
Morbidity and Mortality Conference
Kord Honda, MD
Maya Mattar, MD
Lalitha Nayak, MD
Benigno Rodriguez, MD
Topic: A Case of a 30-year-old Man with Hypercoaguability and Vasculitis with a Long and Complicated Hospital Stay
12 pm Kulas Auditorium
Cancer Center Research in Progress
Gerson lab, Div. of Hem/Onc
Topic: 15-PGDH is a Negative Regulator of Hematopoiesis
4 pm WRB 3-136
New Treatment Paradigms for Melanoma: A Case-based Discussion
Holiday Inn–Cleveland South
National GvHD Health Symposium
Embassy Suites Cleveland-Rockside
Society for Immunotherapy Regional Conference: Advances in Immunotherapy
Intercontinental Hotel and Conference Center at Cleveland Clinic
Point of Care Technologies for Cancer